Page last updated: 2024-12-06

1,2,3,4,5,6,7,8-octahydroacridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1,2,3,4,5,6,7,8-Octahydroacridine: A Versatile Scaffold for Research

**1,2,3,4,5,6,7,8-Octahydroacridine** (also known as 9H-acridine) is a tricyclic organic compound with a central nitrogen atom and a saturated ring system. It acts as a versatile scaffold in research due to its unique properties and potential applications in various fields:

**Structure and Properties:**

* **Tricyclic structure:** This provides a rigid framework for chemical modifications, enabling the development of diverse derivatives with varying biological activities.
* **Nitrogen atom:** This atom acts as a hydrogen bond acceptor, enhancing interactions with biological targets and increasing solubility in aqueous environments.
* **Saturated ring system:** This confers stability and allows for functionalization at various positions on the molecule.

**Research Applications:**

* **Pharmaceutical research:** 1,2,3,4,5,6,7,8-Octahydroacridine derivatives have demonstrated activity against various biological targets:
* **Antimicrobial:** Several derivatives show potent activity against bacteria, fungi, and parasites.
* **Anti-cancer:** Some derivatives exhibit cytotoxic activity against cancer cell lines.
* **Anti-inflammatory:** Certain derivatives have demonstrated anti-inflammatory properties.
* **Central Nervous System (CNS) activity:** Some octahydroacridine derivatives show potential as neuroprotective agents or modulators of neurotransmission.
* **Materials science:** The unique structure of 1,2,3,4,5,6,7,8-octahydroacridine allows for its incorporation into:
* **Polymeric materials:** Derivatives can be incorporated into polymers to enhance their properties, such as mechanical strength or conductivity.
* **Organic light-emitting diodes (OLEDs):** Octahydroacridine derivatives can act as emitters in OLEDs, producing specific colors and enhancing device efficiency.
* **Analytical chemistry:** Derivatives of 1,2,3,4,5,6,7,8-octahydroacridine can be employed as:
* **Fluorescent probes:** Their fluorescent properties allow them to be used for detecting and quantifying specific analytes in various samples.
* **Chiral reagents:** Derivatives can be used to resolve enantiomers (mirror-image molecules) in chiral analysis.

**Importance:**

The combination of its structural features and diverse applications makes 1,2,3,4,5,6,7,8-octahydroacridine an important scaffold for research. Its potential in diverse fields, including pharmaceuticals, materials science, and analytical chemistry, warrants continued investigation and development.

**Further Research:**

* **Developing new derivatives:** Researchers are actively exploring synthetic strategies to create novel 1,2,3,4,5,6,7,8-octahydroacridine derivatives with improved biological activity and/or tailored properties for specific applications.
* **Understanding mechanism of action:** Researchers are studying the mechanisms by which 1,2,3,4,5,6,7,8-octahydroacridine derivatives interact with biological targets and elicit their effects.
* **Optimization and development:** Efforts are underway to optimize the synthesis and formulation of 1,2,3,4,5,6,7,8-octahydroacridine derivatives for potential therapeutic or technological applications.

In conclusion, 1,2,3,4,5,6,7,8-octahydroacridine serves as a valuable scaffold for researchers, offering diverse opportunities for developing novel and beneficial applications across various fields.

1,2,3,4,5,6,7,8-octahydroacridine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID74263
SCHEMBL ID529327
MeSH IDM0392343

Synonyms (20)

Synonym
OPREA1_739795
octahydroacridine
1,2,3,4,5,6,7,8-octahydro-acridine
1658-08-8
acridine, 1,2,3,4,5,6,7,8-octahydro-
1,2,3,4,5,6,7,8-octahydroacridine
inchi=1/c13h17n/c1-3-7-12-10(5-1)9-11-6-2-4-8-13(11)14-12/h9h,1-8h
HMS1665O05
O0197
einecs 216-758-2
FT-0633738
AKOS022181305
SCHEMBL529327
1,2,3,4,5,6,7,8octahydroacridine
LLCXJIQXTXEQID-UHFFFAOYSA-N
mfcd00005032
AS-62681
CS-0206163
T71895
DTXSID00862726
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.47 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]